| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,010 |
9,705 |
$2.89M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,784 |
3,581 |
$2.52M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,132 |
1,290 |
$956K |
| 80053 |
Comprehensive metabolic panel |
12,435 |
10,714 |
$627K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,904 |
2,852 |
$504K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,383 |
10,387 |
$482K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,737 |
4,486 |
$329K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
193 |
169 |
$311K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,836 |
1,513 |
$265K |
| 71046 |
Radiologic examination, chest; 2 views |
2,346 |
1,706 |
$245K |
| 36415 |
Collection of venous blood by venipuncture |
16,958 |
13,889 |
$240K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,863 |
1,793 |
$237K |
| 80061 |
Lipid panel |
4,110 |
3,997 |
$221K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,476 |
2,045 |
$197K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,731 |
1,428 |
$186K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,183 |
1,809 |
$181K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,894 |
2,542 |
$177K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,726 |
1,350 |
$151K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,336 |
1,845 |
$144K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,871 |
2,778 |
$142K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,361 |
840 |
$141K |
| 80305 |
|
2,424 |
1,987 |
$117K |
| 84484 |
|
2,571 |
1,817 |
$110K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
701 |
525 |
$108K |
| 82728 |
|
1,345 |
1,303 |
$101K |
| 70450 |
Computed tomography, head or brain; without contrast material |
284 |
212 |
$98K |
| 83690 |
|
1,848 |
1,571 |
$88K |
| 81001 |
|
4,055 |
3,465 |
$86K |
| 73630 |
|
618 |
498 |
$80K |
| 83605 |
|
1,472 |
1,181 |
$70K |
| 84439 |
|
1,106 |
1,070 |
$66K |
| 71045 |
Radiologic examination, chest; single view |
674 |
555 |
$57K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,612 |
1,452 |
$53K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
511 |
459 |
$46K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
440 |
236 |
$43K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
860 |
836 |
$40K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
252 |
221 |
$39K |
| 85610 |
|
2,127 |
1,640 |
$38K |
| 83880 |
|
483 |
405 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
312 |
285 |
$37K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,090 |
902 |
$37K |
| 87070 |
|
962 |
839 |
$34K |
| 83735 |
|
1,241 |
1,054 |
$32K |
| 87077 |
|
971 |
829 |
$32K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
708 |
476 |
$27K |
| 85379 |
|
437 |
377 |
$26K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
606 |
398 |
$25K |
| 97162 |
|
237 |
231 |
$23K |
| 82607 |
|
281 |
274 |
$21K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,109 |
751 |
$20K |
| 85730 |
|
863 |
743 |
$20K |
| 87186 |
|
504 |
437 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,871 |
1,430 |
$17K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
95 |
71 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
477 |
304 |
$15K |
| 73030 |
|
105 |
67 |
$15K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,429 |
1,232 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
395 |
378 |
$14K |
| 85652 |
|
463 |
441 |
$13K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
269 |
111 |
$13K |
| 85027 |
|
457 |
431 |
$12K |
| 73130 |
|
99 |
74 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
388 |
368 |
$10K |
| 87400 |
|
139 |
100 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
79 |
76 |
$9K |
| 73610 |
|
83 |
61 |
$9K |
| 87807 |
|
71 |
69 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
156 |
142 |
$8K |
| 81003 |
|
467 |
441 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
134 |
73 |
$7K |
| 81025 |
|
256 |
244 |
$7K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
30 |
28 |
$7K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
112 |
110 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
113 |
110 |
$7K |
| 82570 |
|
276 |
272 |
$6K |
| 87430 |
|
135 |
129 |
$6K |
| 82150 |
|
134 |
121 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
51 |
47 |
$6K |
| 82043 |
|
139 |
138 |
$5K |
| 94760 |
|
209 |
172 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
127 |
107 |
$4K |
| A4550 |
Surgical trays |
387 |
230 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
88 |
87 |
$4K |
| G0378 |
Hospital observation service, per hour |
28 |
12 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
57 |
$3K |
| 87040 |
|
79 |
43 |
$3K |
| 84703 |
|
104 |
95 |
$3K |
| 80306 |
|
29 |
25 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
236 |
154 |
$3K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
703 |
549 |
$3K |
| 97161 |
|
26 |
26 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$3K |
| 80143 |
|
32 |
28 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
186 |
145 |
$3K |
| 74018 |
|
12 |
12 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
145 |
121 |
$2K |
| 87081 |
|
26 |
25 |
$2K |
| 80179 |
|
31 |
28 |
$2K |
| 73562 |
|
19 |
14 |
$2K |
| 86140 |
|
78 |
78 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
210 |
151 |
$1K |
| 96376 |
|
15 |
15 |
$1K |
| 97014 |
|
41 |
17 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
16 |
12 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15 |
15 |
$1K |
| 84481 |
|
13 |
12 |
$1K |
| 86038 |
|
16 |
14 |
$1K |
| 82746 |
|
12 |
12 |
$998.10 |
| 97164 |
|
29 |
24 |
$760.32 |
| 93000 |
|
17 |
16 |
$741.12 |
| 93041 |
|
16 |
14 |
$598.64 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$526.35 |
| 82948 |
|
20 |
12 |
$466.21 |
| 85007 |
|
22 |
20 |
$465.60 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
67 |
25 |
$358.41 |
| J2060 |
Injection, lorazepam, 2 mg |
39 |
36 |
$350.36 |
| 0002A |
|
33 |
31 |
$344.04 |
| 81015 |
|
18 |
12 |
$307.23 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
16 |
13 |
$293.62 |
| 87205 |
|
17 |
12 |
$270.00 |
| 83540 |
|
12 |
12 |
$238.47 |
| 86803 |
|
12 |
12 |
$227.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$215.89 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
13 |
$153.52 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
168 |
92 |
$143.59 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
45 |
38 |
$132.10 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$108.30 |
| 0001A |
|
40 |
38 |
$87.59 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
14 |
12 |
$86.33 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
27 |
26 |
$75.87 |
| J1800 |
Injection, propranolol hcl, up to 1 mg |
45 |
42 |
$57.57 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
14 |
12 |
$53.18 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
429 |
314 |
$34.98 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
16 |
12 |
$14.98 |
| T1015 |
Clinic visit/encounter, all-inclusive |
91 |
84 |
$0.00 |
| 80348 |
|
19 |
14 |
$0.00 |
| A9270 |
Non-covered item or service |
5,138 |
3,036 |
$0.00 |